<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR3">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rojek</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Castle</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Dunning</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Horby</surname>
    <given-names>PW</given-names>
   </name>
   <name>
    <surname>Leliogdowicz</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Carson</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola virus disease epidemic</article-title>
  <source>Clin Infect Dis</source>
  <year>2017</year>
  <volume>66</volume>
  <issue>9</issue>
  <fpage>1454</fpage>
  <lpage>1457</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/cix1061</pub-id>
 </element-citation>
</ref>
